Hub : Traits :

Irritability

628 significantly associated models · 84 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 2 43899918 45698128 1 1 8.9e-08 3.3e-08 1.0e-01 91 CAMKMT
2 3 48350366 50144951 8 1 2.7e-09 6.1e-09 1.0e+00 100 CCDC36
3 5 49462228 50836718 2 1 6.4e-08 9.3e-07 1.2e-01 90 PARP8
4 5 87104604 88677293 1 1 3.7e-08 6.8e-10 5.3e-03 80 LINC00461
5 7 11553163 12967449 1 1 1.7e-07 6.0e-08 1.4e-01 93 TMEM106B
6 8 8092025 13120332 35 1 6.9e-17 1.0e-17 6.5e-05 78 AF131215.9
7 8 88801153 89582625 1 1 1.5e-08 4.4e-11 7.4e-04 74 MMP16
8 12 15807367 17456908 1 1 7.8e-08 4.6e-05 3.6e-02 74 MGST1
9 13 110831451 112257226 1 1 1.5e-07 4.6e-06 1.0e+00 100 ANKRD10
10 16 30347731 31758245 6 1 3.6e-10 3.8e-10 2.3e-01 96 HSD3B7
11 16 70624483 72022941 2 1 2.9e-08 7.9e-08 1.3e-01 92 CMTR2
12 17 42774693 45796313 18 1 1.3e-11 1.4e-09 3.5e-01 98 WNT3
13 20 32254831 34109427 4 1 2.1e-13 7.1e-12 8.3e-01 100 TP53INP2
14 22 40472399 42379813 2 1 9.1e-08 7.0e-09 2.5e-02 85 SLC25A17

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder (2018) 1.78 1 0 0.0 0.00 1.0e+00 TP53INP2
Bipolar Disorder or Schizophrenia 2.65 1 1 2.2 0.00 1.0e+00 SLC25A17
Depressed Affect (Nagel 2018) 10.45 7 4 8.9 0.99 4.7e-05 CCDC36 CMTR2 HSD3B7 LINC00461 PARP8 TMEM106B WNT3
Depression (Nagel 2018) 5.18 3 1 2.2 0.00 1.0e+00 CMTR2 TMEM106B WNT3
Intelligence (Savage-Jansen 2018) 2.49 2 2 4.4 0.00 1.0e+00 LINC00461 WNT3
Neuroticism (Nagel 2018) 13.35 9 6 13.3 0.98 2.5e-06 ANKRD10 CMTR2 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Schizophrenia (2018) 2.69 1 0 0.0 0.00 1.0e+00 SLC25A17
Worry (Nagel 2018) 7.57 5 2 4.4 0.99 9.1e-04 HSD3B7 SLC25A17 TMEM106B TP53INP2 WNT3
Major Depression (MDD) 2.92 1 0 0.0 0.00 1.0e+00 TMEM106B
Verbal and Numeric Reasoning (VNR) 2.19 1 0 0.0 0.00 1.0e+00 LINC00461
Breast Cancer 2.31 1 1 2.2 0.00 1.0e+00 WNT3
Ovarian Cancer 2.35 1 1 2.2 0.00 1.0e+00 WNT3
Mean Putamen Volume 2.88 1 0 0.0 0.00 1.0e+00 WNT3
LDL Cholesterol 1.61 1 0 0.0 0.00 1.0e+00 CMTR2
Lupus 2.00 1 0 0.0 0.00 1.0e+00 AF131215.9
Neuroticism (2016) 9.55 4 2 4.4 1.00 1.5e-03 AF131215.9 LINC00461 SLC25A17 WNT3
Primary Biliary Cirrhosis 2.13 1 0 0.0 0.00 1.0e+00 WNT3
Schizophrenia (2014) 2.58 1 0 0.0 0.00 1.0e+00 SLC25A17
Triglycerides 2.98 1 0 0.0 0.00 1.0e+00 TP53INP2
Blood Eosinophil Count 2.07 3 3 6.7 0.00 1.0e+00 CCDC36 SLC25A17 WNT3
Blood Platelet Count 0.59 2 1 2.2 0.00 1.0e+00 LINC00461 WNT3
Blood Red Count 5.53 5 3 6.7 0.81 9.8e-02 ANKRD10 CMTR2 HSD3B7 LINC00461 WNT3
Blood White Count 0.55 2 0 0.0 0.00 1.0e+00 LINC00461 WNT3
Heel T-Score 2.43 4 3 6.7 -0.78 2.2e-01 CCDC36 MMP16 SLC25A17 WNT3
BMI 2.89 3 1 2.2 0.00 1.0e+00 HSD3B7 LINC00461 MMP16
Height 2.02 5 5 11.1 -0.79 1.1e-01 CAMKMT CMTR2 TMEM106B TP53INP2 WNT3
Waist Hip Ratio (WHR) 2.85 2 2 4.4 0.00 1.0e+00 MMP16 WNT3
Systolic Blood Pressure 0.96 1 0 0.0 0.00 1.0e+00 CMTR2
Smoking Status 2.52 2 0 0.0 0.00 1.0e+00 CCDC36 WNT3
Allergy or Eczema 1.62 1 1 2.2 0.00 1.0e+00 SLC25A17
Lung FEV1/FVC ratio 1.33 1 0 0.0 0.00 1.0e+00 MMP16
Lung FVC 5.19 3 3 6.7 0.00 1.0e+00 HSD3B7 TP53INP2 WNT3
Neuroticism 11.33 8 5 11.1 0.98 2.4e-05 CMTR2 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Hair Pigment 8.85 3 2 4.4 0.00 1.0e+00 SLC25A17 TP53INP2 WNT3
Tanning 17.06 1 1 2.2 0.00 1.0e+00 TP53INP2
Hand grip strength (left) 3.89 3 1 2.2 0.00 1.0e+00 CAMKMT MMP16 WNT3
Sensitivity / hurt feelings 8.20 2 2 4.4 0.00 1.0e+00 AF131215.9 WNT3
Frequency of depressed mood in last 2 weeks 5.63 3 0 0.0 0.00 1.0e+00 AF131215.9 TMEM106B WNT3
Hearing difficulty/problems: Yes 1.88 1 0 0.0 0.00 1.0e+00 HSD3B7
Relative age of first facial hair 5.70 1 1 2.2 0.00 1.0e+00 WNT3
Systolic blood pressure, automated reading 2.68 2 1 2.2 0.00 1.0e+00 AF131215.9 CCDC36
Impedance of leg (right) 4.68 4 4 8.9 0.67 3.3e-01 AF131215.9 LINC00461 MMP16 TP53INP2
Leg fat-free mass (left) 3.38 5 4 8.9 -0.71 1.8e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Trunk fat percentage 3.34 5 2 4.4 -0.32 6.0e-01 CCDC36 HSD3B7 LINC00461 SLC25A17 WNT3
Hand grip strength (right) 2.78 2 1 2.2 0.00 1.0e+00 CAMKMT WNT3
Current tobacco smoking 2.56 1 0 0.0 0.00 1.0e+00 SLC25A17
Fed-up feelings 7.81 6 2 4.4 0.99 4.6e-05 AF131215.9 ANKRD10 CMTR2 LINC00461 PARP8 WNT3
Relative age voice broke 4.88 1 1 2.2 0.00 1.0e+00 WNT3
Age when periods started (menarche) 1.90 1 0 0.0 0.00 1.0e+00 CCDC36
Heel bone mineral density (BMD) T-score, automated (left) 4.74 2 1 2.2 0.00 1.0e+00 AF131215.9 CCDC36
Qualifications: CSEs or equivalent 1.51 1 0 0.0 0.00 1.0e+00 WNT3
High blood pressure 2.90 2 1 2.2 0.00 1.0e+00 AF131215.9 CCDC36
Medication: Levothyroxine sodium 1.53 1 0 0.0 0.00 1.0e+00 AF131215.9
Sitting height 4.06 3 3 6.7 0.00 1.0e+00 CAMKMT TP53INP2 WNT3
Body mass index (BMI) 3.63 4 2 4.4 -0.38 6.2e-01 AF131215.9 HSD3B7 LINC00461 MMP16
Impedance of leg (left) 5.02 5 4 8.9 0.51 3.8e-01 AF131215.9 LINC00461 MMP16 TP53INP2 WNT3
Leg predicted mass (left) 3.39 5 4 8.9 -0.71 1.8e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Trunk fat mass 3.32 3 2 4.4 0.00 1.0e+00 HSD3B7 LINC00461 WNT3
Waist circumference 2.38 2 1 2.2 0.00 1.0e+00 HSD3B7 LINC00461
Past tobacco smoking 2.37 1 0 0.0 0.00 1.0e+00 WNT3
Nervous feelings 8.39 4 2 4.4 0.98 1.6e-02 AF131215.9 SLC25A17 TP53INP2 WNT3
Frequency of tenseness / restlessness in last 2 weeks 6.62 2 1 2.2 0.00 1.0e+00 TMEM106B WNT3
Hearing difficulty/problems with background noise 2.06 1 0 0.0 0.00 1.0e+00 WNT3
Hair/balding pattern: Pattern 2 3.06 1 1 2.2 0.00 1.0e+00 WNT3
Forced vital capacity (FVC) 4.78 2 2 4.4 0.00 1.0e+00 HSD3B7 WNT3
Heel bone mineral density (BMD) T-score, automated (right) 4.99 3 2 4.4 0.00 1.0e+00 AF131215.9 CCDC36 MMP16
Ever unenthusiastic/disinterested for a whole week 2.68 1 0 0.0 0.00 1.0e+00 WNT3
Mouth/teeth dental problems 2.30 1 0 0.0 0.00 1.0e+00 WNT3
Neuroticism score 15.25 9 6 13.3 0.98 3.1e-06 AF131215.9 ANKRD10 HSD3B7 LINC00461 PARP8 SLC25A17 TMEM106B TP53INP2 WNT3
Weight 3.22 5 3 6.7 -0.45 4.4e-01 AF131215.9 CAMKMT HSD3B7 LINC00461 TP53INP2
Impedance of arm (right) 4.83 7 5 11.1 0.10 8.3e-01 AF131215.9 CCDC36 LINC00461 MMP16 TMEM106B TP53INP2 WNT3
Arm fat percentage (right) 2.75 3 1 2.2 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Trunk fat-free mass 2.79 4 3 6.7 -0.95 5.1e-02 AF131215.9 CAMKMT MMP16 TP53INP2
Hip circumference 3.64 5 4 8.9 -0.44 4.6e-01 AF131215.9 HSD3B7 LINC00461 MMP16 TP53INP2
Time employed in main current job 3.43 1 1 2.2 0.00 1.0e+00 WNT3
Worrier / anxious feelings 8.96 4 3 6.7 0.98 2.4e-02 AF131215.9 HSD3B7 SLC25A17 WNT3
Frequency of tiredness / lethargy in last 2 weeks 4.40 2 1 2.2 0.00 1.0e+00 CCDC36 TMEM106B
Hair/balding pattern: Pattern 3 6.14 1 1 2.2 0.00 1.0e+00 WNT3
Number of live births 1.74 1 0 0.0 0.00 1.0e+00 WNT3
Forced expiratory volume in 1-second (FEV1) 5.28 2 2 4.4 0.00 1.0e+00 HSD3B7 WNT3
Pulse rate 1.58 1 0 0.0 0.00 1.0e+00 CCDC36
Qualifications: A levels/AS levels or equivalent 1.77 1 0 0.0 0.00 1.0e+00 LINC00461
Mouth/teeth dental problems: Dentures 2.16 1 0 0.0 0.00 1.0e+00 TP53INP2
Depression (self-reported) 3.34 1 0 0.0 0.00 1.0e+00 TMEM106B
Forced expiratory volume in 1-second (FEV1), Best measure 5.24 2 2 4.4 0.00 1.0e+00 HSD3B7 WNT3
Impedance of arm (left) 4.70 6 4 8.9 0.11 8.4e-01 AF131215.9 CCDC36 MMP16 TMEM106B TP53INP2 WNT3
Arm fat mass (right) 3.29 3 2 4.4 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Trunk predicted mass 2.85 4 3 6.7 -0.95 5.3e-02 AF131215.9 CAMKMT MMP16 TP53INP2
Standing height 2.22 4 3 6.7 -0.99 5.2e-03 CAMKMT TMEM106B TP53INP2 WNT3
Tense / 'highly strung' 9.85 5 2 4.4 0.99 8.8e-04 AF131215.9 HSD3B7 SLC25A17 TMEM106B TP53INP2
Seen doctor (GP) for nerves, anxiety, tension or depression 5.12 1 1 2.2 0.00 1.0e+00 TMEM106B
Hair/balding pattern: Pattern 4 7.69 1 1 2.2 0.00 1.0e+00 WNT3
Peak expiratory flow (PEF) 4.12 3 1 2.2 0.00 1.0e+00 AF131215.9 CAMKMT WNT3
Qualifications: O levels/GCSEs or equivalent 1.92 1 0 0.0 0.00 1.0e+00 LINC00461
Blood clot in the leg (DVT) 2.29 1 0 0.0 0.00 1.0e+00 TP53INP2
Medication: Paracetamol 3.67 1 1 2.2 0.00 1.0e+00 WNT3
Headache pain in last month 4.05 1 1 2.2 0.00 1.0e+00 WNT3
Hypothyroidism/myxoedema (self-reported) 2.11 1 1 2.2 0.00 1.0e+00 AF131215.9
High blood pressure (siblings) 2.99 1 0 0.0 0.00 1.0e+00 TMEM106B
Forced vital capacity (FVC), Best measure 4.98 2 2 4.4 0.00 1.0e+00 HSD3B7 WNT3
Body fat percentage 2.98 3 1 2.2 0.00 1.0e+00 HSD3B7 LINC00461 WNT3
Leg fat percentage (right) 2.49 2 2 4.4 0.00 1.0e+00 HSD3B7 LINC00461
Arm fat-free mass (right) 3.37 5 3 6.7 -0.76 1.4e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Comparative body size at age 10 3.17 5 1 2.2 -0.47 4.2e-01 AF131215.9 CAMKMT HSD3B7 LINC00461 TP53INP2
Number of full brothers 2.95 1 0 0.0 0.00 1.0e+00 WNT3
Worry too long after embarrassment 6.64 5 1 2.2 0.99 9.2e-04 AF131215.9 ANKRD10 LINC00461 TP53INP2 WNT3
Seen a psychiatrist for nerves, anxiety, tension or depression 3.80 1 0 0.0 0.00 1.0e+00 TMEM106B
Age at first live birth 3.29 1 0 0.0 0.00 1.0e+00 AF131215.9
Qualifications: College or University degree 2.64 2 2 4.4 0.00 1.0e+00 LINC00461 WNT3
Emphysema/chronic bronchitis 2.77 1 0 0.0 0.00 1.0e+00 WNT3
Medication for pain relief, constipation, heartburn 3.35 1 1 2.2 0.00 1.0e+00 WNT3
Neck or shoulder pain in last month 2.34 1 0 0.0 0.00 1.0e+00 CMTR2
Whole body fat mass 3.16 3 1 2.2 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Leg fat mass (right) 3.16 3 2 4.4 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Arm predicted mass (right) 3.38 5 3 6.7 -0.77 1.3e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Pulse rate, automated reading 2.07 2 1 2.2 0.00 1.0e+00 CCDC36 LINC00461
Alcohol intake frequency. 2.92 1 1 2.2 0.00 1.0e+00 WNT3
Comparative height size at age 10 2.02 4 2 4.4 -0.74 2.6e-01 CAMKMT CMTR2 TP53INP2 WNT3
Suffer from 'nerves' 4.80 2 1 2.2 0.00 1.0e+00 AF131215.9 WNT3
Leg pain on walking 2.17 1 0 0.0 0.00 1.0e+00 WNT3
Supplements: Vitamin C 2.13 1 0 0.0 0.00 1.0e+00 WNT3
Hypertension (Self-reported) 2.85 2 1 2.2 0.00 1.0e+00 AF131215.9 CCDC36
Illnesses of father: Heart disease 1.77 1 0 0.0 0.00 1.0e+00 WNT3
Forced expiratory volume in 1-second (FEV1), predicted 1.62 1 1 2.2 0.00 1.0e+00 TP53INP2
Whole body fat-free mass 3.08 5 4 8.9 -0.77 1.3e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Leg fat-free mass (right) 3.35 5 4 8.9 -0.74 1.5e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm fat percentage (left) 3.07 3 1 2.2 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Handedness (chirality/laterality): Left-handed 3.30 1 1 2.2 0.00 1.0e+00 WNT3
Mood swings 11.82 6 4 8.9 1.00 2.9e-05 AF131215.9 CMTR2 HSD3B7 SLC25A17 TMEM106B WNT3
Loneliness, isolation 5.26 2 0 0.0 0.00 1.0e+00 TMEM106B WNT3
Mouth/teeth dental problems: Mouth ulcers 3.75 1 1 2.2 0.00 1.0e+00 WNT3
Forced expiratory volume in 1-second (FEV1), predicted percentage 4.55 2 2 4.4 0.00 1.0e+00 HSD3B7 WNT3
Whole body water mass 3.11 5 4 8.9 -0.77 1.3e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Leg predicted mass (right) 3.35 5 4 8.9 -0.74 1.5e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Arm fat mass (left) 3.30 3 2 4.4 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Number of self-reported non-cancer illnesses 2.28 1 0 0.0 0.00 1.0e+00 TMEM106B
Average weekly champagne plus white wine intake 2.28 1 0 0.0 0.00 1.0e+00 WNT3
Miserableness 7.35 3 3 6.7 0.00 1.0e+00 AF131215.9 TMEM106B WNT3
Guilty feelings 5.48 2 1 2.2 0.00 1.0e+00 AF131215.9 WNT3
Medication: Blood pressure 2.41 1 0 0.0 0.00 1.0e+00 AF131215.9
High cholesterol (Self-reported) 2.02 1 0 0.0 0.00 1.0e+00 HSD3B7
Medication: Bendroflumethiazide 2.74 1 1 2.2 0.00 1.0e+00 AF131215.9
Medication: Paracetamol 3.39 1 1 2.2 0.00 1.0e+00 WNT3
Basal metabolic rate 3.14 5 5 11.1 -0.73 1.6e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Leg fat percentage (left) 2.44 3 1 2.2 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Arm fat-free mass (left) 3.18 5 3 6.7 -0.76 1.3e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2
Average weekly beer plus cider intake 2.79 1 0 0.0 0.00 1.0e+00 AF131215.9
Risk taking 2.59 1 0 0.0 0.00 1.0e+00 AF131215.9
Fractured/broken bones in last 5 years 2.93 1 0 0.0 0.00 1.0e+00 WNT3
Diastolic blood pressure, automated reading 2.59 2 2 4.4 0.00 1.0e+00 AF131215.9 LINC00461
Vascular/heart problems diagnosed by doctor 2.60 2 1 2.2 0.00 1.0e+00 AF131215.9 CCDC36
Cholesterol lowering medication 1.57 1 0 0.0 0.00 1.0e+00 HSD3B7
Pain experienced in last month 2.25 1 0 0.0 0.00 1.0e+00 WNT3
Basal cell carcinoma (self-reported) 2.45 1 0 0.0 0.00 1.0e+00 TP53INP2
Deep venous thrombosis (DVT) (self-reported) 2.50 1 0 0.0 0.00 1.0e+00 TP53INP2
Impedance of whole body 5.34 6 6 13.3 0.21 6.9e-01 AF131215.9 CCDC36 LINC00461 MMP16 TP53INP2 WNT3
Leg fat mass (left) 3.16 3 2 4.4 0.00 1.0e+00 AF131215.9 HSD3B7 LINC00461
Arm predicted mass (left) 3.38 5 3 6.7 -0.77 1.3e-01 AF131215.9 CAMKMT LINC00461 MMP16 TP53INP2

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 14 0.401 1.7
GTEx Adipose Visceral Omentum 10 0.491 1.7
GTEx Adrenal Gland 9 0.618 1.8
GTEx Artery Aorta 17 0.571 1.7
GTEx Artery Coronary 12 1.014 1.9
GTEx Artery Tibial 11 0.292 1.7
GTEx Brain Caudate basal ganglia 5 0.543 1.8
GTEx Brain Cerebellar Hemisphere 8 0.537 1.9
GTEx Brain Cerebellum 8 0.404 1.7
GTEx Brain Cortex 8 0.773 1.9
GTEx Brain Frontal Cortex BA9 8 0.866 1.9
GTEx Brain Hippocampus 4 0.763 1.7
GTEx Brain Hypothalamus 4 0.678 1.7
GTEx Brain Nucleus accumbens basal ganglia 8 0.925 1.8
GTEx Brain Putamen basal ganglia 4 0.641 1.9
GTEx Breast Mammary Tissue 10 0.507 1.7
GTEx Breast Mammary Tissue (Male) 10 0.838 1.6
GTEx Breast Mammary Tissue (Female) 8 0.487 1.8
GTEx Cells EBV-transformed lymphocytes 11 0.773 2.0
GTEx Cells Transformed fibroblasts 11 0.262 1.7
GTEx Colon Sigmoid 11 0.752 1.8
GTEx Colon Transverse 15 0.727 1.8
GTEx Esophagus Gastroesophageal Junction 12 0.830 1.9
GTEx Esophagus Mucosa 15 0.452 1.8
GTEx Esophagus Muscularis 16 0.495 1.8
GTEx Heart Atrial Appendage 9 0.570 1.8
GTEx Heart Left Ventricle 9 0.588 1.8
GTEx Liver 3 0.418 1.8
GTEx Lung 15 0.522 1.7
GTEx Muscle Skeletal 9 0.311 1.7
GTEx Nerve Tibial 15 0.347 1.7
GTEx Ovary 8 0.881 1.9
GTEx Pancreas 13 0.797 1.8
GTEx Pituitary 7 0.628 1.8
GTEx Prostate 5 0.599 1.8
GTEx Skin Not Sun Exposed Suprapubic 15 0.610 1.8
GTEx Skin Sun Exposed Lower leg 17 0.467 1.7
GTEx Small Intestine Terminal Ileum 6 1.302 2.1
GTEx Spleen 7 0.496 1.8
GTEx Stomach 10 0.688 1.8
GTEx Testis 17 0.539 1.8
GTEx Thyroid 19 0.475 1.7
GTEx Uterus 9 1.587 2.1
GTEx Vagina 6 0.945 1.9
GTEx Whole Blood 8 0.401 1.7
METSIM Adipose 5 0.108 1.5
NTR Blood 6 0.250 1.7
ROSMAP Brain Pre-frontal Cortex 22 0.501 1.9
YFS Blood 4 0.087 1.5
CommonMind Brain Pre-frontal Cortex 8 0.149 1.6
The Cancer Genome Atlas Bladder Urothelial Carcinoma 7 0.423 1.7
The Cancer Genome Atlas Breast Invasive Carcinoma 8 0.182 1.6
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 3 0.273 1.7
The Cancer Genome Atlas Colon Adenocarcinoma 5 0.242 1.7
The Cancer Genome Atlas Esophageal Carcinoma 4 0.584 1.9
The Cancer Genome Atlas Glioblastoma Multiforme 2 0.196 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 5 0.184 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 11 0.268 1.6
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 8 0.390 1.7
The Cancer Genome Atlas Brain Lower Grade Glioma 8 0.186 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 4 0.362 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 6 0.204 1.6
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 5 0.200 1.7
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 6 0.377 1.6
The Cancer Genome Atlas Pancreatic Adenocarcinoma 4 0.241 1.7
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 5 0.377 1.8
The Cancer Genome Atlas Prostate Adenocarcinoma 11 0.238 1.6
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.145 1.6
The Cancer Genome Atlas Soft Tissue Sarcoma 2 0.187 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.187 1.8
The Cancer Genome Atlas Stomach Adenocarcinoma 6 0.356 1.7
The Cancer Genome Atlas Testicular Germ Cell Tumors 3 0.235 1.7
The Cancer Genome Atlas Thyroid Carcinoma 9 0.174 1.6
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 3 0.591 1.8